Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
Editor Note: For more information about this release, please scroll to bottom.
LONDON, May 21, 2014 /PRNewswire/ --
The markets on Tuesday, May 20, 2014 ended on a negative note as the Dow Jones Industrial Average finished at 16,374.31, down 0.83% and the NASDAQ Composite closed at 4,096.89, down 0.70%. The S&P 500 edged 0.65% lower, to finish the day at 1,872.83. The losses were broad based as nine out of ten sectors ended the session in negative. During the session, Telecommunication Services, Industrials and Consumer Discretionary sectors ended in negative, while some positive momentum was observed in the Utilities sector. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Masco Corporation (NYSE: MAS), Hecla Mining Company (NYSE: HL), Banco Santander S.A. (NYSE: SAN) and Bristol-Myers Squibb Company (NYSE: BMY). Free technical research on MAS, HL, SAN and BMY can be downloaded upon signing up at:
On Tuesday, Masco Corp.'s stock declined 1.70%, closing the day at $20.82. The stock recorded a trading volume of 6.06 million shares, much above its three months average volume of 4.69 million shares. The stock oscillated between $20.70 and $21.20 during the trading session. Although, Masco Corp.'s shares have gained 3.33% in the previous three trading sessions, it has declined 5.62% in the last one month and 8.56% on YTD basis. The S&P 500 Industrials Sector Index advanced 2.55% in the previous three months, while the S&P 500 gained 1.80% during the same period. Masco Corp.'s stock is trading below its 50-day and 200-day moving averages of $21.61 and $21.36, respectively. Moreover, shares of the company traded at a PE ratio of 22.75 and have a Relative Strength Index (RSI) of 53.71. Sign up today to read free research on MAS at:
Hecla Mining Co.'s stock finished Tuesday's session 2.31% lower at $2.96. A total of 6.47 million shares were traded, which was much above its three months average volume of 5.42 million shares. The stock moved between $2.94 and $3.05 during the session. Over the previous three trading sessions and over the last one month, Hecla Mining Co.'s shares have fallen by 1.99% and 3.58%, respectively. Additionally, the company's stock has lost 3.90% since the beginning of this year. The S&P 500 Materials Sector Index gained 3.19% in the previous three months, while the S&P 500 Index advanced 1.80% during the same period. The company's shares are trading below their 50-day and 200-day moving averages. Moreover, the stock's 200-day moving average of $3.19 is greater than its 50-day moving average of $3.16. Further, Hecla Mining Co.'s stock has an RSI of 44.35. Sign up today to read free research on HL at:
On Tuesday, shares in Banco Santander S.A. recorded a trading volume of 6.20 million shares, which was above its three months average volume of 5.17 million shares. The stock ended the day at $10.00, which was 0.70% above its previous day's closing, and registered an intraday range of $9.98 and $10.08. Banco Santander S.A.'s shares have advanced 1.83% in the last one month and 11.98% in the previous three months. Additionally, from the beginning of 2014, the company's stock has gained an upside of 10.25%. The S&P 500 Financials Sector Index advanced 1.24% in the previous three months, while the S&P 500 Index gained 1.80% during the same period. Banco Santander S.A.'s stock is trading above its 50-day and 200-day moving averages of $9.62 and $8.78, respectively. Furthermore, shares of the company have an RSI of 52.99. Sign up today to read free research on SAN at:
Shares in Bristol-Myers Squibb Co. traded between $48.47 and $49.33 before closing the day 1.18% lower at $48.76. The company's stock reported a trading volume of 7.33 million shares on Tuesday, which was below its three months average volume of 8.67 million shares. Bristol-Myers Squibb Co.'s shares have declined 1.42% in the last one month, 9.45% in the previous three months and 8.26% on YTD basis. Shares of the company traded at a PE ratio of 27.69. The S&P 500 Health Care Sector Index advanced 2.04% in the last one month, while the S&P 500 Index edged 0.43% higher during the same period. The stock is trading below its 50-day and 200-day moving averages. Moreover, Bristol-Myers Squibb Co.'s 50-day moving average of $51.26 is greater than its 200-day moving average of $50.00. Additionally, the company's stock has an RSI of 42.65. Sign up today to read free research on BMY at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
©2012 PR Newswire. All Rights Reserved.